Using neuroimaging to predict relapse in stimulant dependence: A comparison of linear and machine learning models.


Journal

NeuroImage. Clinical
ISSN: 2213-1582
Titre abrégé: Neuroimage Clin
Pays: Netherlands
ID NLM: 101597070

Informations de publication

Date de publication:
2019
Historique:
received: 05 07 2018
revised: 08 01 2019
accepted: 10 01 2019
pubmed: 22 1 2019
medline: 4 1 2020
entrez: 22 1 2019
Statut: ppublish

Résumé

Relapse rates are consistently high for stimulant user disorders. In order to obtain prognostic information about individuals in treatment, machine learning models have been applied to neuroimaging and clinical data. Yet few efforts have been made to test these models in independent samples or show that they can outperform linear models. In this exploratory study, we examine whether machine learning models relative to linear models provide greater predictive accuracy and less overfitting. This longitudinal study included 63 methamphetamine-dependent (training sample) and 29 cocaine-dependent (test sample) individuals who completed an MRI scan during residential treatment. Linear and machine learning models predicting relapse at a one-year follow up that were previously developed in the methamphetamine-dependent sample using neuroimaging and clinical variables were applied to the cocaine-dependent sample. Receiver operating characteristic analysis was used to assess performance using area under the curve (AUC) as the primary outcome. Twelve individuals in the cocaine-dependent sample remained abstinent, and 17 relapsed. The linear models produced more accurate prediction in the training sample than the machine learning models but showed reduced performance in the testing sample, with AUC decreasing by 0.18. The machine learning models produced similar predictive performance in the training and test samples, with AUC changing by 0.03. In the test sample, neither the linear nor the machine learning model predicted relapse at rates above chance. Although machine learning algorithms may have advantages, in this study neither model's performance was sufficient to be clinically useful. In order to improve predictive models, stronger predictor variables and larger samples are needed.

Identifiants

pubmed: 30665102
pii: S2213-1582(19)30026-9
doi: 10.1016/j.nicl.2019.101676
pmc: PMC6350259
pii:
doi:

Substances chimiques

Methamphetamine 44RAL3456C

Types de publication

Comparative Study Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

101676

Subventions

Organisme : NIDA NIH HHS
ID : R01 DA016663
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA027797
Pays : United States
Organisme : NIAAA NIH HHS
ID : R00 AA024778
Pays : United States
Organisme : NIAAA NIH HHS
ID : T32 AA013525
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA018307
Pays : United States
Organisme : NIMH NIH HHS
ID : K23 MH113708
Pays : United States
Organisme : NIAAA NIH HHS
ID : F31 AA027169
Pays : United States

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Joshua L Gowin (JL)

Departments of Radiology and Psychiatry, University of Colorado School of Medicine, Aurora, CO, United States. Electronic address: joshua.gowin@ucdenver.edu.

Monique Ernst (M)

Section on Neurobiology of Fear and Anxiety, National Institute of Mental Health, Bethesda, MD, United States.

Tali Ball (T)

Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, United States.

April C May (AC)

Department of Psychiatry, University of California San Diego, La Jolla, CA, United States.

Matthew E Sloan (ME)

Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States.

Susan F Tapert (SF)

Department of Psychiatry, University of California San Diego, La Jolla, CA, United States.

Martin P Paulus (MP)

Department of Psychiatry, University of California San Diego, La Jolla, CA, United States; Laureate Institute for Brain Research, Tulsa, OK, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH